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Abstract
Rare inherited cardiovascular diseases are frequently caused by mutations in genes that are essential for the formation and/
or function of the cardiovasculature. Hereditary Haemorrhagic Telangiectasia is a familial disease of this type. The majority
of patients carry mutations in either Endoglin (ENG) or ACVRL1 (also known as ALK1) genes, and the disease is characterized
by arteriovenous malformations and persistent haemorrhage. ENG and ACVRL1 encode receptors for the TGFb superfamily
of ligands, that are essential for angiogenesis in early development but their roles are not fully understood. Our goal was to
examine the role of Acvrl1 in vascular endothelial cells during vascular development and to determine whether loss of
endothelial Acvrl1 leads to arteriovenous malformations. Acvrl1 was depleted in endothelial cells either in early postnatal
life or in adult mice. Using the neonatal retinal plexus to examine angiogenesis, we observed that loss of endothelial Acvrl1
led to venous enlargement, vascular hyperbranching and arteriovenous malformations. These phenotypes were associated
with loss of arterial Jag1 expression, decreased pSmad1/5/8 activity and increased endothelial cell proliferation. We found
that Endoglin was markedly down-regulated in Acvrl1-depleted ECs showing endoglin expression to be downstream of
Acvrl1 signalling in vivo. Endothelial-specific depletion of Acvrl1 in pups also led to pulmonary haemorrhage, but in adult
mice resulted in caecal haemorrhage and fatal anaemia. We conclude that during development, endothelial Acvrl1 plays an
essential role to regulate endothelial cell proliferation and arterial identity during angiogenesis, whilst in adult life
endothelial Acvrl1 is required to maintain vascular integrity.
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Introduction
ACVRL1 (activin receptor like kinase1) is a TGFb/BMP type I
receptor that is required for angiogenesis in vivo [1]. It is a
membrane protein that is expressed on endothelial cells (ECs), and
has a particularly strong affinity for BMP9 and BMP10 ligands [2].
BMP9 (which is present in serum) has been shown to signal
through ACVRL1 in ECs and to inhibit angiogenesis in a context
specific manner [3,4]. Furthermore, binding of BMP9 to
ACVRL1 (in complex with the BMP type 2 receptor) leads to
phosphorylation of SMAD1/5/8 transcription factors which
regulate downstream gene expression. Patients who are heterozy-
gous for loss of function mutations in ACVRL1 develop the vascular
disorder Hereditary Haemorrhagic Telangiectasia (HHT) type 2
[5]. A very similar disease (HHT type 1) is caused by mutations in
the TGFb/BMP co-receptor endoglin. Type I and type 2 HHT
form the majority of cases of this disease which is characterised by
persistent intermittent bleeding from small vascular lesions in the
nose and GI tract and by numerous sporadic larger arteriovenous
malformations (AVMs) caused by direct connections between
arteries and veins that can affect lung, brain and liver [6]. This
clinical phenotype points to the importance of ACVRL1 and
endoglin in vascular development and in maintaining blood vessel
integrity.
When Acvrl1 is depleted from ECs during late foetal
development, neonatal mice show systemic enlargement of
arteriovenous interconnections, consistent with extensive shunting
from arteries to veins [7]. On the other hand, ubiquitous loss of
Acvrl1 in adult mice leads to gastrointestinal bleeding that is also a
feature of HHT2 patients [7]. Real time imaging following dermal
injury revealed de novo AVM formation in these mice, and pointed
to angiogenesis as a trigger of abnormal vessel remodelling in the
absence of Acvrl1 in the adult vasculature [7]. This was recently
confirmed in a study that showed VEGF stimulated angiogenesis
in the brain led to the development of abnormal vessels resembling
AVMs in mice with endothelial specific loss of Acvrl1, but not in
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controls [8]. Cranial AVMs that develop following loss of Acvrl1 in
a zebrafish model were associated with an abnormal increase in
endothelial cell proliferation, which occurs partly in response to
blood flow [9,10]. Furthermore, recent work, using adenoviral
delivery of the extracellular domain of human ACVRL1 to act as a
ligand trap in neonatal mice, showed that removal of BMP9 (and
other Acvrl1-binding ligands) in the mouse circulation led to
hyperbranching of the retinal plexus, consistent with defects in
Notch signalling [11]. However, the effect of losing the endoge-
nous endothelial Acvrl1 receptor in this model has not yet been
addressed. We therefore derived a mouse model in which we can
trigger endothelial-specific depletion of Acvrl1 in the first week of
postnatal life to investigate its role during angiogenesis in vivo. In
addition, in the context of HHT, we aimed to compare the
vascular phenotype following specific depletion of Acvrl1 from
vascular ECs (Acvrl1-iKOe) in this study, with the previously
reported phenotype resulting from endothelial specific loss of
endoglin (Eng-iKOe) [12].
Methods
Ethics Statement
All animal experiments were performed under UK home office
licence with approval from Newcastle University ethical review
committee.
Mice
Floxed Acvrl1 (Acvrl1fl/fl) mice, and endothelial-specific tamox-
ifen inducible Cre line (Cdh5(PAC)CreERT2) were genotyped by
genomic PCR as previously described [12–15]. Neonatal
Cdh5(PAC)CreERT2;Acvrl1fl/fl mice and Acvrl1fl/fl control littermates
were injected subcutaneously with 0.3 mg tamoxifen at postnatal
day (P)4 and tissues were harvested at P6, no later than
40 hours post injection. To inactivate Acvrl1 in adult life,
Cdh5(PAC)CreERT2;Acvrl1fl/fl mice aged 10 to 12 weeks were
injected intraperitoneally with 2 mg tamoxifen on two occasions,
separated by 1 day; tissues and blood were harvested for analysis
10 days after the first injection. Controls were tamoxifen treated
Acvrl1fl/fl littermates. To reduce variation, only male mice were
used in the adult part of the study as there is a gender difference in
response to ubiquitous Acvrl1 depletion in adult life [7].
Retinal immunofluorescence staining and analysis
Mouse eyes were enucleated immediately post-mortem, and
retinas prepared and stained as previously described [12,16].
Essentially retinas were briefly fixed in 4% (w/v) paraformalde-
hyde in PBS prior to staining. Vascular staining was performed
with Alexa488-conjugated B. Simplicifolia isolectin B4 (Invitrogen)
and immunostaining with primary antibodies to alpha smooth
muscle actin (anti-aSMA-Cy3, Sigma), desmin (Millipore), Jag1
(Santa Cruz), CD31 and Endoglin (BD biosciences), EphB4 and
Acvrl1 (R&D) [12]. Secondary antibodies conjugated with
Alexa594 or Alexa488 (Invitrogen) were used to detect unconju-
gated primary antibodies. Analysis of branchpoints, filopodia, tip
cells and the percentage area covered by isolectin-positive
endothelial cells were calculated according to previously reported
guidelines [17]. Quantitation of AVM incidence was calculated
from fields of view (5300 mm64460 mm) using images from 24
whole retinas, as previously described [12]. To measure venous
diameters, at least 3 veins per retina were measured at 3 positions
(200 mm, 250 mm and 300 mm) from the centre of the retina, and 4
retinas were analysed per group. Pericyte coverage of the central
vascular capillaries was calculated from 5 fields of view
(355 mm6265 mm) per retina using maximum intensity projection
confocal images and NIS-Element software (Nikon). Pericyte
coverage was calculated as the ratio of area covered by desmin
positive muscle cells and normalised to the area covered by CD31-
positive endothelial cells. To detect endothelial cell proliferation,
pups were injected subcutaneously with thymidine analogues,
either 50 mg EdU or 100 mg BrdU per gram body weight two
hours prior to harvesting tissues. To visualise EdU positive cells,
retinas were stained using Click-iT chemistry according to
manufacturer’s instructions (Click-iT imaging kit, Invitrogen). To
detect BrdU, retinas were treated briefly with 6 mol/L HCl to
denature the DNA prior to staining with anti-BrdU-Alexa594
(Invitrogen). A total of 4 fields of view (142061060 mm) were
analysed in the central region of each retina and the number of
proliferating ECs was normalised to isolectin stained vessel area for
6 control and 6 Acvrl1-iKOe retinas. Visualization of ECs with
anti-podocalyxin (R&D) to detect the apical endothelial surface
and anti-phospho-Smad1/5/8 (NEB) to detect Smad1/5/8
activation was performed following heat-based antigen retrieval
on paraffin retinal sections as previously described [18]. Stained
retinas were flat mounted in prolong gold mountant including dapi
for nuclear staining, (Invitrogen) and examined using a NikonA1R
confocal microscope. Quantitation of pSmad1/5/8 staining
intensity using NIS-elements software was performed on 56
endothelial nuclei from 3 Acvrl1-iKOe mutant retinas and 65
endothelial nuclei from 3 littermate controls.
Analysis of Mouse Lung and Caecal Tissue
Lungs and caeca were fixed in 4% paraformaldehyde or
formalin, embedded in paraffin, sectioned and stained with
haematoxylin and eosin (H&E) and mounted in histomount.
Alternatively, paraffin sections were subjected to heat-based
antigen retrieval and stained with isolectin B4 and anti-aSMA,
then mounted in prolong gold (Invitrogen). Tissues were examined
using a Zeiss Axioimager microscope.
Purification of ECs from tissues
Retinal ECs, or primary ECs from lung tissue, were isolated
from wild-type and Acvrl1-iKOe neonates (aged P6). Freshly
dissected retinal tissue was finely minced and incubated in 10 mL
Dulbecco modified Eagle medium containing 200 U/ml collage-
nase I (Gibco) for 45 minutes at 37uC. The cells were filtered
through a 40 um nylon mesh, recovered by centrifugation (500 g
for 5 minutes at 4uC) and resuspended in Buffer 1 (0.1% bovine
serum albumin, 2 mM EDTA, pH7.4 in PBS). ECs were
incubated with anti-CD31 (BD Pharmingen)-coupled magnetic
beads (Invitrogen) for 30 minutes at 4uC and isolated from the cell
mixture using a magnetic separator (Dynal). Bead-EC conjugates
were washed 5 times with Buffer 1 and centrifuged for 5 minutes at
3400 g at 4uC, and the supernatant removed. The purified retinal
ECs were then snap frozen and stored at 280uC until required.
Total RNA was extracted from purified retinal ECs using the
RNAeasy Micro kit (Qiagen). RNA concentration and purity was
calculated by measuring the absorbance at 260 and 280 nm using
a Nanodrop spectrophotometer (ThermoScientific) and 100 ng of
the total RNA was used to prepare template cDNA using RT2
First Strand Kit (Qiagen), according to manufacturers’ instruc-
tions. Purified ECs from at least 5 Acvrl1-iKOe and 5 control
retinas were used to prepare cDNA in four independent
experiments using HotStarTaq DNA Polymerase Kit (Qiagen).
PCR was used to establish EC purification by comparing Cdh5
and CD31 expression in EC and non-EC fractions after cell
sorting. Ve-cadherin (Cdh5) transcripts were detected using
forward primer 59-ACCGTGGGTGTGTGCAAG-39 and reverse
primer 59-TTTCTTCACGTCGATCATGGTG-39 and expres-
Arteriovenous Malformations and Acvrl1
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sion of CD31 (Pecam1) was determined using forward primer 59-
AAGCGGTCGTGAATGACAC-39 and reverse primer 59-
TTTGGCTGCAACTATTAAGGTG-39. Levels of b-actin were
determined using the forward primer 59-TGAACCCTAAGGC-
CAACCGTG-39 and the reverse primer 59-GCTCA-
TAGCTCTTCTCCAGGG-39. PCR was performed with 35
cycles of denaturation (30 s at 97uC), annealing (30 s at 58.2uC),
and extension (90 s at 72uC), followed by a final extension of
5 min at 72uC for CD31/Pecam1 and b-actin. Cycle conditions
for Cdh5 were 35 cycles (97uC, 64uC, 72uC).
Mouse neonatal lung ECs were prepared as previously
described [19]. Briefly, lung tissue from pups was cut into small
fragments and digested with collagenase/dispase solution (Roche)
and dispersed mechanically into single-cell suspension. ECs were
purified from cell suspension using anti-CD31 antibody conjugat-
ed to Dynabeads using a magnetic particle concentrator and
cultured to passage 3 in Endothelial Cell Basal Medium MV2
(PromoCell). Cells were then seeded onto multiwell slides and
immunostained for CD31, endoglin and Acvrl1 expression before
imaging with a Zeiss Axioimager and digital camera.
Q-PCR
RNA was prepared from retinal ECs (P6) using the RNAeasy
Micro kit (Qiagen) and RNA concentration and purity assessed
using a Nanodrop spectrophotometer as above. cDNA was made
using RT2 First Strand Kit (Qiagen), according to manufacturers’
instructions. Q-PCR was performed using a SYBR Green-based
real time PCR custom array (SABioscience) of 85 genes involved
in angiogenesis. ECs from at least 5 Acvrl1-iKOe and 5 control
retinas were used to prepare cDNA in four replicate experiments
for the custom array. For data analysis, the RT2 Profiler PCR
Array software was used and statistical analyses performed. This
package uses DDCt-based fold change calculations with respect to
the average C(t) of 3 housekeeping genes: B2m, Gapdh and Actb
and the Student’s t-test to calculate two-tail, equal variance p-
values.
Oxygen saturation and blood parameters
Oxygen saturation was measured in adult mice on the day
before the first tamoxifen injection by pulse oxymetry (MouseOx;
Starr Life Sciences Corp.), and over the subsequent 11 days. The
mouse was anesthetised by isoflurane mixed with medical air, and
the sensor was placed on a hind limb. Blood chemistry parameters
were obtained using blood harvested by cardiac puncture from
anesthetised adult mice (10 days after the first tamoxifen injection)
and analysed on a CC8+ cartridge (Abaxis) using an i-STAT
portable reader (Abbott Laboratories, Princeton, NJ).
Statistical Analysis
Data were analysed by two-way analysis of variance, and paired
Student’s t-test using Graphpad Prism (version 5, Graphpad
Software Inc., La Jolla, CA, USA). Data are expressed as mean
6SEM, and and p,0.05 was considered to be statistically
significant.
Results
Endothelial specific depletion of Acvrl1 in neonates leads
to rapid mortality associated with pulmonary
haemorrhage
Acvrl1 is expressed in the veins, arteries and capillaries of the
neonatal retina at postnatal day (P) 6 (Figure 1A,B). Tamoxifen
injection of Cdh5(PAC)CreERT2;Acvrl1fl/fl neonatal mice led to
efficient loss of Acvrl1 protein expression in the neonatal retina
to generate Acvrl1-iKOe mice (Figure 1C,D). By 48 hours post
injection, Acvrl1-iKOe showed severe respiratory distress leading
to rapid mortality. The timing was therefore optimised to examine
neonates at 40 hours post tamoxifen injection, which was after
Acvrl1 protein depletion, but before the severe adverse symptoms
began. Examination of Acvrl1-iKOe neonatal lungs revealed
haemorrhage from the distal small capillaries, which was absent in
controls, but we observed no detectable loss of vascular smooth
muscle cells (vSMCs) from the pulmonary blood vessels (Figure
S1).
Endothelial specific depletion of Acvrl1 in neonates leads
to retinal arteriovenous malformations and
hyperbranching
We chose to investigate the effect of endothelial depletion of
Acvrl1 in the retinal vasculature using a similar approach to one
we had used previously [12]. This approach has a number of
advantages. First, the neonatal retinal plexus undergoes a well
characterised process of vascularisation in the first week of life
allowing identification of any aberrant angiogenesis events in the
absence of endothelial Acvrl1 [20]. Second, individual endothelial
cells can be visualised within a simple two dimensional vascular
permitting analysis of key parameters such as cell proliferation,
smooth muscle coverage, arterial and venous identity as well as
cell-specific signalling in vivo. Using this approach we identified
numerous vessel abnormalities in the Acvrl1-iKOe mutants
compared with controls, including AVMs, enlarged veins and
hyperbranching of the capillary plexus (Figure 1E–H). Approxi-
mately 60% of Acvrl1-iKOe neonatal retinas showed AVMs (14/
24 retinas); and when present there were usually multiple AVMs
(average number per retina = 2.7). Even more frequently, enlarged
veins were observed in 70% of the Acvrl1-iKOe retinas (Figure 1F
& H); the mean vein width was 23.99+/2 1.4 mm in control
retinas and 42.62+/22.3 mm in Acvrl1-iKOe retinas (p,0.001).
Increased vascular branching (100% incidence) was associated
with higher vascular density (Figure 2B) and greater numbers of
filopodia, consistent with the presence of increased numbers of tip
cells in the central region of the plexus, an area where the tip cell
phenotype is normally suppressed (Figure 2). There was no
significant difference between Acvrl1-iKOe and control retinas in
progression of the plexus towards the edge of the retina (Figure S2)
suggesting there was no defect in migration. Pericyte coverage of
the arteries and veins was normal in Acvrl1-iKOe retinas, but
capillaries showed decreased pericyte coverage in Acvrl1-iKOe
mutants compared with controls (Figure 3).
As AVMs can be caused by loss of arterial and venous identity,
we next investigated whether arteries and veins of the Acvrl1-iKOe
retinal plexus retained expression of key venous and arterial
molecular markers. We found that expression of the venous
marker, EphB4, was retained in the veins of Acvrl1-iKOe retinas
(Figure 4A,B), but there was markedly reduced jagged 1 (Jag1)
expression in the mutant arteries compared with controls,
suggesting loss of arterial identity (Figure 4C,D). Interestingly,
AVMs in the Acvrl1 deficient retinas also expressed the venous
marker EphB4, consistent with AVMs possessing a venous identity
(Figure 4B). Using thymidine analogues to monitor proliferating
cells we observed there was increased EC proliferation in AVMs,
as well as in the enlarged veins, in comparison with littermate
controls, pointing to an abnormal increase in EC proliferation
underlying the enlargement of both veins and AVMs in Acvrl1-
iKOe retinas (Figure 4E–H).
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Endothelial specific depletion of Acvrl1 in neonates leads
to reduced phospho-activation of Smad1/5/8 and
changes in downstream gene expression
As Acvrl1 normally responds to circulating ligands by
phosphorylating Smad1/5/8, we used antibodies to detect the
phosphorylated form of Smad1/5/8 in Acvrl1-KOe retinas and
found that pSmad1/5/8 activity was significantly reduced in
Acvrl1-KOe ECs compared with controls (Figure 5A–C). We
therefore aimed to test whether there was a reduction in Id1, Id2
or Id3 transcripts, which lie downstream of this pathway. To do
this we compared the relative transcript levels in purified retinal
ECs of Acvrl1-iKOe mutants and controls using a custom
SABiosciences qPCR array. First, we established a method to
reproducibly purify neonatal retinal endothelial cells and con-
firmed endothelial cell enrichment using rtPCR for pan endothe-
lial markers Cdh5 and CD31 (Figure 5D). Retinal ECs were then
used to evaluate changes in expression of a range of genes (Table
S1) that had either been reported to be dysregulated following loss
of Acvrl1 [10,21] or were downstream of BMP9 signalling [22–24]
or were associated with a related phenotype. Of the 85 candidate
genes tested, 14 were found to be significantly down-regulated by
over 50%, but no genes were up regulated (Table 1). Acvrl1
transcripts were reduced by 5.7 fold, consistent with efficient gene
knockdown, and Id3 (but not Id1 or Id2) was downregulated 3.6-
fold, in agreement with the observed reduction in pSmad1/5/8
activity. Expression of Notch1 and Flt1 were reduced in line with
the altered tip cell phenotype [25,26], and the vasoregulators
eNOS and Ptgs2 were also downregulated. Reduced expression of
three key transcription factors, FoxC1, FoxC2 and Sox17, each
with known roles in the regulation of angiogenesis [27,28], was
Figure 1. Loss of endothelial Acvrl1 expression leads to abnormalities in the neonatal retinal vascular plexus. Acvrl1 expression in
control retinas at P6 is seen in veins, arteries and capillaries (A,B) and is efficiently knocked down 40 hours after tamoxifen injection (C,D). Loss of
Acvrl1 protein in endothelial cells in the Acvrl1-iKOe mouse leads to AVMs (F, arrow), enlarged veins (compare veins in F and E as well as H and G) and
hyperbranching (F, asterisks). Arteries are muscularised in both Acvrl1-iKOe and control retinas, as indicated by staining for alpha smooth muscle actin
(aSMA) positive smooth muscle cells (E,F). An AVM at higher magnification (H) contrasts with the normal capillary network seen in control retinas (G).
Abbreviations a, artery; v, vein. Scale bar = 400 mm A–D; 500 mm E and F; 25 mm G and H.
doi:10.1371/journal.pone.0098646.g001
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also observed. However, at 33-fold reduction, endoglin was the
most dramatically downregulated transcript in the array. Endoglin
depletion in Acvrl1-iKOe neonatal retinas was confirmed at the
protein level and was particularly evident in capillary ECs of the
retina (Figure 6A–F). This effect was also seen in other tissues:
analysis of neonatal pulmonary ECs from Acvrl1-iKOe and
control mice confirmed reduced endoglin expression following
depletion of Acvrl1 (Figure 6 G–L).
Endothelial specific depletion of Acvrl1 in adult life leads
to caecal haemorrhage
To investigate the role of Acvrl1 in ECs in adult life, we also
examined the vasculature of adult retinas following EC-specific
depletion of Acvrl1 in mice aged between 10 and 12 weeks. Loss of
Acvrl1 in adult retinal ECs had no detectable effect on vessel
organisation or vessel branching, consistent with a requirement
for angiogenesis to generate AVMs (Figure S3). However,
approximately 10 days after Acvrl1 depletion was initiated, these
mice developed severe GI bleeding, evident as black faeces (Figure
S4) in a similar way to previously reported for the ubiquitous
Acvrl1 knockout mouse [7]. Post mortem examination at day 11
revealed the source of bleeding was located to fragile microvessels
in the villi of the caecum (Figure S4). To investigate the effect of
blood loss on oxygen transport to the peripheral vasculature, mice
were monitored pre- and post- tamoxifen treatment for oxygen
saturation which was found to be significantly reduced at day 11
compared with controls (Figure S4). Cardiac (left ventricle) blood
parameters were measured at day11 and the mean haematocrit
level was 35.6% of packed cell volume in control mice but was
significantly reduced to 13.2% (p,0.01) in Acvrl1-iKOe mice.
Similarly, the mean haemoglobin levels were 12 g/dL in controls,
but only 4.5 g/dL in the Acvrl1-iKOe (p,0.01), suggesting that
haemorrhage was the major cause of low peripheral oxygen
saturation (Table S2). However, blood gas analysis of cardiac left
Figure 2. Hypervascularity of the Acvrl1-iKOe retinal plexus. Neonatal Acvrl1-iKOe retinas show increased vascular branching compared with
controls (A,B). Vessel density (C), vessel branch points (D), and density of filopodia (E) are all significantly increased in Acvrl1-iKOe retinas (P6)
compared with controls. *p,0.05. Scale bar = 25 mm.
doi:10.1371/journal.pone.0098646.g002
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ventricular blood from Acvrl1-iKOe mutants showed that the
oxygen saturation was unchanged (Table S2), suggesting that
pulmonary AVMs were either absent or asymptomatic in vivo.
Discussion
We have shown that loss of Acvrl1 from ECs in neonates leads
to a significant increase in vessel branching and increased numbers
Figure 3. Reduced pericyte coverage of capillaries in neonatal Acvrl1-iKOe retinas. Desmin staining revealed that pericyte coverage of
capillaries in Acvrl1-iKOe retinas (D–F) was reduced compared with controls (A–C). Quantitation of the ratio of desmin to CD31 staining confirmed
that the increased endothelial cell density in Acvrl1-iKOe retinas was not accompanied by an equivalent increase in pericyte density (G). *p,0.05;
***p,0.001. Scale bar = 20 mm A,B; 25 mm D-I.
doi:10.1371/journal.pone.0098646.g003
Figure 4. Loss of arterial identity and increased EC proliferation in neonatal Acvrl1-iKOe retinas. Retinal veins show retention of venous
marker EphB4 similar to control (A,B) and AVMs are also EphB4 positive (arrow, B). Jag1 expression in arteries of Acvrl1-iKOe retinas is reduced
compared with controls (C,D). EdU labelling (E,F) reveals a significant increase in EC proliferation in mid plexus capillaries (G) and veins (H) of Acvrl1-
iKOe retinas compared with controls. Increased EC proliferation is also associated with AVMs in Acvrl1-iKOe mutants (arrow, F). *p,0.05; **p,0.01.
Scale bar = 50 mm A and B; 200 mm C and D; 100 mm E and F.
doi:10.1371/journal.pone.0098646.g004
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of tip cells in the angiogenic neonatal retinal plexus, similar to the
retinal phenotype observed when an ACVRL1 ligand trap was
used to reduce Acvrl1 signalling [11]. This hyperbranching
phenotype was also observed following depletion of BMP10 in
retinas of the BMP9 null mouse [29], pointing to BMP9 and
BMP10 as the activating ligands for Acvrl1 signalling in vivo.
Furthermore, increased numbers of tip cells and hyperbranching
resulted from endothelial-specific depletion of Smad1 and Smad5
in developing embryos [30]. In agreement with this, we observed
that neonatal Acvrl1-iKOe retinas also showed reduced endothe-
lial pSmad1/5/8 levels. Taken together, these findings are
mutually supportive and consistent with BMP9/10 signalling
through Acvrl1 to activate Smad1/5/8 to synergise with Notch
signalling. This acts to minimise tip cell formation in the stalk and
phalanx ECs during angiogenesis in vivo [11,30,31]. In addition,
our data suggests that Acvrl1 activity would also affect Notch
signalling by regulating Notch1 and Jag1 expression.
The interaction of Acvrl1 and Notch signalling defects during
the development of AVMs is less clear. Firstly, both loss and gain
of Notch signalling can lead to AVM formation. For example,
Notch mutant embryos develop AVMs, thought to be due to
fusions of veins and arteries following loss of arterial and venous
identity [32]. On the other hand, upregulation of Notch4 or
Notch1 signalling also leads to AVM formation [33,34]. However,
AVMs that develop following increased Notch4 signalling are
reversible once excessive Notch signalling is normalised [34], but it
remains to be determined to what extent the reversible AVMs are
a feature of arteriovenous fusion, dysregulated vascular smooth
muscle tone or excess endothelial cell proliferation. In HHT, it is
not clear whether AVMs form as a result of lost arteriovenous
identity. From analysis of the mouse models we can say that AVMs
are a feature of Eng-iKOe retinas where arteriovenous identity was
maintained. In contrast, the Acvrl1-iKOe mutant retinas show a
striking reduction in arterial Jag1 expression. This finding is
consistent with a previous report showing that Jag1 expression is
regulated by BMP9 [22] and agrees with the loss of arterial
identity that was first reported in Acvrl1 null mouse embryos [35].
In contrast, venous identity is preserved, as judged by retention of
EphB4 expression in the Acvrl1-iKOe retinal veins. Furthermore,
AVMs in the Acvrl1-iKOe neonatal retinas also expressed EphB4,
consistent with a venous identity for these arteriovenous connec-
tions. In contrast to a previous report [7] we observed that loss of
endothelial Acvrl1 did not lead to detectable loss of vascular
smooth muscle cells. This difference is likely to be because we are
only examining events that occur within 40 hours of tamoxifen
treatment, whereas the previous study involved Acvrl1 depletion
from approximately E17 to P3 providing more opportunity for
pulmonary vessel remodelling to occur [7]. However, we did
confirm the microvessel haemorrhage seen in the postnatal lungs
following loss of Acvrl1 [7], demonstrating the endothelial cause of
this fragility defect.
The majority of HHT patients carry mutations in either
endoglin (HHT type 1) or ACVRL1 (HHT type 2) genes [5,36].
Retinal vascular malformations have been reported in HHT
patients although they are not considered a major clinical problem
[37,38]. Both HHT type 1 and HHT type 2 patient groups have a
similar clinical presentation, suggesting that endoglin and
ACVRL1 perform a similar function. Endoglin is a co-receptor
for the TGFb superfamily, has a high binding affinity for BMP9
[39,40], and promotes signalling through ACVRL1 [41]. Exam-
ination of the neonatal retinal plexus following loss of endothelial
endoglin (Eng-iKOe) [12] or Acvrl1 (this study) has revealed
Figure 5. Reduced pSmad1/5/8 activity and loss of endoglin expression in endothelial cells of neonatal Acvrl1-iKOe retinas. Retinal
sections stained for pSmad1/5/8 (green) reveal Smad1/5/8 activation in vascular cells and neural cells in control retinas (A). Confocal analysis of
podocalyxin staining (red) was used to identify the apical surface of endothelial cells in retinal blood vessels. Reduced pSmad1/5/8 staining can be
seen in endothelial cells in Acvrl1-iKOe retinas (B), and was quantified using confocal software. Statistical analysis of pSmad1/5/8 staining intensity
shows a significant reduction in endothelial cells of Acvrl1-iKOe mutants compared with controls (C). Expression of pan-endothelial markers by rtPCR
was used to confirm retinal endothelial cell (EC) purification by antibody conjugated magnetic beads. Pecam1 and Cdh5 were detected in the cDNA
prepared from EC fractions compared to the non-EC (N-EC) fractions prepared from Acvrl1-iKOe and control retinas. Expression of b-actin was used as
a positive control.
doi:10.1371/journal.pone.0098646.g005
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interesting similarities and differences. In both cases, increased
endothelial cell proliferation contributed to the AVMs, which also
showed venous identity. The AVMs developed in a similar way
but there was no loss of arterial identity in the Eng-iKOe,
suggesting that loss of arterial or venous identity is not a
prerequisite for AVM formation in HHT. Furthermore, Eng-
iKOe retinas differed from Acvrl1-iKOe retinas in that they did
not exhibit hyperbranching or show altered pSmad1/5/8 levels,
suggesting that some BMP9/10 signalling was preserved in the
absence of endothelial endoglin, and consistent with the role of
endoglin as a facilitator of ligand binding, rather than being
essential for signalling. Furthermore, loss of endothelial Acvrl1 in
our study leads to a rapid lethality, which appeared to be due to
microhaemorrhage of the lung, whereas Eng-iKOe neonates are
viable.
There was a striking reduction of endoglin expression in Acvrl1-
iKOe mice so that reduced endoglin expression is a common
feature of both Eng-iKOe and Acvrl1-iKOe genotypes. This
finding agrees with the reduced endoglin expression previously
reported in blood outgrowth ECs and in activated monocytes from
HHT type 2 patients [21,42], although endoglin expression did
not appear to be reduced in HUVECs or activated monocytes
from HHT2 patients in an earlier study [43]. As endoglin
expression is downstream of BMP9/10 signalling, [22–24] then
reduced Acvrl1 activity would explain the decrease in endoglin
expression. This finding is compatible with a positive feedback
loop: endoglin promotes Acvrl1 signalling [41] and is also
expressed downstream of Acvrl1 signalling. We observed no
reciprocal downregulation of Acvrl1 expression in Eng-iKOe
mutants (data not shown). Together these findings suggest that
BMP9/10 signalling is not sufficiently disturbed to reduce
pSmad1/5/8 in Eng-iKOe mice and that Acvrl1 is more critical
for BMP9/10 signalling in vivo. Figure 7 shows a diagrammatic
summary of the disrupted signalling pathway in Acvrl1-iKOe and
Eng-iKOe mice. Intriguingly, it is also possible that the features
common to both Eng-iKOe and Acvrl1-iKOe phenotypes such as
AVM formation (summarised in Table 2) may be primarily due to
loss of endoglin. This hypothesis could be tested in future studies
by restoring endoglin expression to Acvrl1-iKOe mice using a
transgenic or related approach.
In addition to Acvrl1 and endoglin, 83 candidate genes were
examined for changes in transcript levels in Acvrl1-iKOe retinal
ECs (Table S1) and 12 of these genes were downregulated.
Reduced Notch1 expression may contribute to decreased Notch
Figure 6. Endothelial cells from Acvrl1-iKOe mice show loss of endoglin expression. Endoglin expression was reduced in Acvrl1-iKOe
retinas (E) compared with controls (B) and this was particularly marked in the capillaries. Representative capillary regions indicated in B and E are
shown in digital zoom in C and F, respectively. *p,0.05. Scale bar = 20 mm A–B; 100 mm D,E,F,H. Purified lung endothelial cells from control (Acvrl1fl/fl)
and Acvrl1-iKOe neonatal mice were immunostained for the pan endothelial marker CD31 to confirm endothelial cell purity (G,J). Cells from the
Acvrl1-iKOe mice showed not only loss of Acvrl1 protein (K), but also reduced endoglin expression (L) compared with controls (I). Dapi was used to
stain cell nuclei and inset in G shows no primary antibody control. Scale bar = 50 mm.
doi:10.1371/journal.pone.0098646.g006
Arteriovenous Malformations and Acvrl1
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e98646
signalling in these retinas [25], but we were unable to detect a
significant change in transcript levels of the Notch immediate
downstream effector genes, Hes1 and Hey1 in vivo. However, we
did observe reduced VegfC levels that may also contribute to the
lymphangiogenesis defects seen in mice treated with an Acvrl1
ligand trap [44]. Further studies comparing vascular-specific and
lymphatic-specific Acvrl1 knockouts are required in order to
determine their relative contributions to VegfC transcript levels.
Furthermore, expression of FoxC1 and FoxC2, which encode
transcription factors involved in regulation of angiogenesis
upstream of Notch, are also reduced in Acvrl1-iKOe retinas and
may contribute to Notch signalling defects. Moreover, FoxC2 is
regulated by BMP9 and plays a role in lymphatic development
[45]. It is also relevant here that compound knockouts for FoxC1
and FoxC2 transcription factors result in mouse embryos with
AVMs resulting from a fusion of veins and arteries similar to those
Table 1. Changes in transcript levels in ECs following knockdown of Acvrl1 expression.
Gene Fold Down-regulation P value Potential Role Reference
Acvrl1 5.7 0.0029 Target gene
Eng 33.4 0.0029 Endoglin promotes Acvrl1 signalling [41]
Id3 3.59 0.038 Transcription factor downstream of pSmad1/5 signalling [41]
FoxC1 4.61 0.038 Regulate angiogenesis and lymphangiogenesis [27]
FoxC2 2.97 0.011
Fzd4 3.04 0.038 Involved in neural angiogenesis [28]
Sox17 2.29 0.011
Lrp5 1.8 0.029
Nos3 2.42 0.033 Regulate vascular tone, downregulated in endoglin mutants. [46,47]
Ptgs2 1.9 0.004
Sele 1.98 0.011 Regulated by BMP9 and involved in leucocyte interactions with ECs. [24]
Flt1 1.57 0.032 Production of sFlt1 a ‘ligand sink’ for VEGFA, required for efficient lateral Notch
signalling
[53]
VegfC 3.82 0.0075 Regulates lymphangiogenesis. [54]
Notch1 3.95 0.036 Regulates tip cell-stalk cell phenotype in angiogenesis [25]
Quantitative PCR using a custom array of 85 genes involved in angiogenesis revealed changes in transcript levels of the 14 listed genes.
doi:10.1371/journal.pone.0098646.t001
Figure 7. Diagrammatic Summary of Normal and Disrupted Signalling following Acvrl1 Depletion in Endothelial Cells. In normal
endothelial cells endoglin promotes BMP9/10 signalling through the ACVRL1/BMPR2 receptor complex (as well as the ACVRL1/TGFBR2 complex, not
shown). ACVRL1 phosphorylates SMAD1/5/8 which is then able to move to the nucleus (in combination with SMAD4) to regulate downstream
expression of many genes. BMP9 signalling leads to increased endoglin expression [22–24] which in turn promotes ACVRL1 signalling in a positive
feedback loop. In the absence of ACVRL1, Smad1/5/8 signalling is reduced and endoglin is no longer expressed. On the other hand, when endoglin is
depleted from endothelial cells, residual signalling through Acvrl1 is able to proceed, but at a lower efficiency.
doi:10.1371/journal.pone.0098646.g007
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seen in Acvrl1 null embryos [27,35]. Levels of eNos and Ptgs2 (also
known as Cox2) transcripts were downregulated 2.4 and 1.9 fold,
respectively, in Acvrl1-iKOe retinal ECs. These genes are both
involved in vasomotor control and have been reported as reduced
in Endoglin deficient mice [46,47]. We also observed reduced
pericyte coverage of the Acvrl1-iKOe retinal capillaries, similar to
a previous report describing local Acvrl depletion in adult cerebral
vessels exposed to angiogenic stimuli [48]. However, we detected
no significant reduction in Pdgfb expression in our custom array
analysis (not shown), so the pericyte defects in our model may
therefore relate to the increased proliferative status of the Acvrl1-
iKOe ECs rather than defects in Pdgf signalling.
In contrast to neonatal Acvrl1-iKOe mice, no AVMs were
detected in retinas of adult Acvrl1-iKOe mice, consistent with our
hypothesis of angiogenesis-dependent AVM formation. However,
bleeding from the caecum, a pouch like structure that lies between
the ileum and colon, was sufficiently severe to cause a fatal
anaemia. Even though the caecum is much smaller in human than
mouse, caecal AVMs have been reported in HHT [49] although
GI bleeding in HHT patients is more frequently associated with
the stomach and upper duodenum [50]. It is not clear why
different vascular beds are susceptible to bleeding in HHT, but loss
of endothelial Acvrl1 in the mouse leads to increased vessel
fragility even in fully formed vessels of the adult caecum, whereas
AVM formation in the retina occurs only in the context of
developmental angiogenesis and vessel remodelling.
In conclusion, this study reveals the importance of endothelial
Acvrl1 signalling in regulating vascular branching and endothelial
cell proliferation during angiogenesis in vivo. We also confirm the
angiogenesis dependence of AVM formation. In adult HHT
patients, inflammation is likely to be the most frequent trigger of
angiogenic responses, and therefore anti-inflammatory drugs may
play a protective role in controlling lesion development. Our
findings also impact on the wider role of ACVRL1 in regulating
cardiovascular pathophysiology [51] and the development of anti-
ACVRL1 therapies[52] for treating cancer patients.
Supporting Information
Figure S1 Lung defects in neonatal Acvrl1-iKOe mice.
H&E stained lung sections show extensive haemorrhage in the
lung capillaries of Acvrl1-iKOe pups at P6 (B) compared with age
matched controls (A). However there was no detectable loss of
supporting vascular smooth muscle cells in the pulmonary blood
vessels (B,C). Lung vasculature was revealed using isolectin
staining (green) and smooth muscle cells were detected using
anti-alpha smooth muscle actin (aSMA, red). Abbreviations: a,
artery; br, bronchiole; v, vein. Scale bar = 100 um.
(TIF)
Figure S2 No reduction in progression of the retinal
vascular plexus in neonatal Acvrl1-iKOe retinas. The
relative distance covered by the vascular plexus was calculated as
the ratio of the vascular radius, indicated by the blue arrow, and
the retinal radius, indicated by the red arrow in 3 separate regions
for each retina. The size of each retina was calculated as the mean
of the retinal radii and mean values are shown +/2 standard
error. Scale bar = 500 um.
(TIF)
Figure S3 Normal vasculature of adult Acvrl1-iKOe
retinas. No vascular abnormalities were detected in vessels from
Acvrl1-iKOe (D–E) adult retinas compared with control retinas
(A–C). Acvrl1 was depleted in endothelial cells during adult life
and retinas were stained for vascular smooth muscle cells using
anti-aSMA (red) and for ECs with isolectin (green). Scale
bar = 500 um.
(TIF)
Figure S4 Adult Acvrl1-iKOe mice develop GI bleeding
from the caecum. Tamoxifen was given to adult mice (on day 1
and day 3 as indicated by black arrows) to generate Acvrl1-iKOe
mice. Peripheral oxygen saturation was significantly reduced in
Acvrl1-iKOe adult mice at day 11* p,0.05 (A). GI bleeding was
first observed by black faeces (inset in D), compare with normal
faeces (inset in C), approximately 9 days after the first tamoxifen
injection. Analysis of the GI tract showed bleeding was localised to
the caecum, which appeared intensely dark coloured (D)
compared with the caecum from control mice (C). Furthermore,
the contents of the small intestine proximal to the caecum were
normal in colour (asterisk in D), whilst the content of the large
intestine immediately distal to the caecum was much darker
indicating a significant blood content (arrow in D). H&E stained
caecal sections revealed bleeding from fragile vessels in the caecal
villi of adult Acvrl1-iKOe mice (arrows, F).
(TIF)
Table S1 Genes used in custom array qPCR analysis to
evaluate changes in transcription following loss of
Acvrl1. (* indicates housekeeping genes used for data normalisa-
tion).
(DOCX)
Table 2. Summary of key differences in the neonatal retinal vascular plexus when either Acvrl1 or Eng is depleted from endothelial
cells.
Phenotype Acvrl1-iKOe *Eng-iKOe
AVMs Present Present
Vessel Branching Increased Increased only at periphery
Angiogenesis Delay No Yes
Venous Identity Preserved, but veins enlarged Preserved, but veins enlarged
Arterial Identity Reduced Preserved
Endothelial Cell Proliferation Increased Increased
Smad1/5 Phosphorylation in Endothelial Cells Reduced No change detected
NB All relative terms (eg ‘increased’ and ‘reduced’) are used with respect to these features in normal (control) retina. *See reference [12] for further details of the Eng-
iKOe phenotype.
doi:10.1371/journal.pone.0098646.t002
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Table S2 Blood Gas Analysis of Acvrl1-iKOe Adult Mice.
Blood from adult male Acvrl1-iKOe and control mice (aged 12
weeks) was taken by cardiac puncture under terminal anaesthesia
and analysed using a CG8+ cartridge with an Istat portable
reader. Blood values are expressed as mean 6SEM.
(DOCX)
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